Compare VFF & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | IVVD |
|---|---|---|
| Founded | 1989 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.1M | 437.1M |
| IPO Year | 2013 | 2021 |
| Metric | VFF | IVVD |
|---|---|---|
| Price | $2.81 | $1.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 959.3K | ★ 3.4M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 184.38 | 79.02 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $215,937,000.00 | $53,426,000.00 |
| Revenue This Year | $12.19 | $61.57 |
| Revenue Next Year | $18.08 | $41.42 |
| P/E Ratio | $10.67 | ★ N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $0.57 | $0.49 |
| 52 Week High | $4.99 | $3.07 |
| Indicator | VFF | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 55.73 |
| Support Level | $2.70 | $1.41 |
| Resistance Level | $2.94 | $1.77 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 61.64 | 83.33 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.